| Literature DB >> 32655907 |
Nicolai Petry1, Salima A Al-Maamary2, Bradley A Woodruff3, Samia Alghannami2, Saleh M Al-Shammakhi2, Ibtesam K Al-Ghammari2, Vilma Tyler4, Fabian Rohner1, James P Wirth1.
Abstract
A national cross-sectional survey was conducted to estimate the prevalence of anaemia, micronutrient deficiencies, haemoglobin disorders and over- and undernutrition in children and women of reproductive age in Oman. Wasting and stunting were found in 9.3% and 11.4% of children aged 0-59 months, respectively, while 4.2% were overweight or obese. In addition, 23.8% were anaemic and 10.2%, 9.5% and 10.6% had iron, vitamin A and vitamin D deficiencies, respectively. Sickle cell and β-thalassaemia genetic traits were present in 5.3% and 4.2% of children and 4.7% and 2.8% of women, respectively. Overall, 9.1% of Omani women were underweight and 59.2% were overweight or obese. The prevalence of anaemia was 27.8%, while iron, folate, vitamin B12 and vitamin D deficiencies affected 24.8%, 11.6%, 8.9% and 16.2%, respectively. Anaemia among both children and women and the prevalence of overweight and obesity in women are the most concerning nutritional problems in Oman. © Copyright 2020, Sultan Qaboos University Medical Journal, All Rights Reserved.Entities:
Keywords: Avitaminosis; Iron-Deficiency Anemia; Malnutrition; Micronutrients; Nutrition Disorders; Oman; Vitamin B 12 Deficiency; Vitamin D Deficiency
Mesh:
Substances:
Year: 2020 PMID: 32655907 PMCID: PMC7328830 DOI: 10.18295/squmj.2020.20.02.005
Source DB: PubMed Journal: Sultan Qaboos Univ Med J ISSN: 2075-051X
Anemia, micronutrient indicators (6–59 months) and anthropometric measures (0–59 months), among Omani children
| Parameter | Mean or prevalence | 95% CI | |
|---|---|---|---|
| (N = 2,531) | |||
| Haemoglobin in g/dL | 11.6 | 11.5–11.6 | |
| Anaemia | 23.8% | 21.4–26.4% | |
| (N = 1,077) | |||
| Plasma ferritin | 31.4 | 29.8–33.1 | |
| ID | 10.2% | 7.8–13.3% | |
| IDA | 1.6% | 1.1–2.3% | |
| Vitamin A status | (N = 1,083) | ||
| Plasma RBP in μmol/L | 0.99 | 0.97–1.00 | |
| VAD | 9.5% | 7.5–12.1% | |
| (N = 1,036) | |||
| Plasma 25-OHD in nmol/L | 18.6 | 18.0–19.1 | |
| VDD | 10.6% | 8.0–13.5% | |
| VDI | 53.8% | 49.7–57.9% | |
| (N = 1,109) | |||
| Sickle cell trait | 5.3% | 3.4–8.3% | |
| β-thalassaemia | 4.2% | 2.3–7.4% | |
| (N = 1,083) | |||
| CRP in mg/L | 2.8 | 2.2–3.5 | |
| AGP in g/L | 0.71 | 0.67–0.74 | |
| Incubation | 4.5% | 3.2–6.4% | |
| Early convalescence | 8.1% | 5.9–11.0% | |
| Late convalescence | 7.5% | 5.6–10.0% | |
| No inflammation | 79.8% | 76.2–83.1% | |
| (N = 2,976) | |||
| Birth weight in kg | 3.0 | 3.0–3.0 | |
| Low birth weight | 11.7% | 10.1–13.4% | |
| (N = 2,920) | |||
| HA z-score | −0.63 | −0.68 to −0.58 | |
| Any stunting | 11.4% | 9.8–13.1% | |
| Moderate stunting | 8.7% | 7.4–10.1% | |
| Severe stunting | 2.7% | 2.1–3.5% | |
| (N = 2,869) | |||
| WH z-score | −0.40 | −0.45 to −0.35 | |
| Any wasting | 9.3% | 7.9–11.0% | |
| Moderate wasting | 6.2% | 5.1–7.6% | |
| Severe wasting | 3.1% | 2.3–4.2% | |
| (N = 2,869) | |||
| Normal | 86.5% | 84.7–88.1% | |
| Overweight or obese | 4.2% | 3.4–5.1% | |
| Overweight | 3.1% | 2.4–4.0% | |
| Obesity | 1.1% | 0.7–1.7% | |
| (N = 2945) | |||
| Mean WA z-score | −0.64 | −0.71 to −0.57 | |
| Any underweight | 11.2% | 9.6–13.1% | |
| Moderate underweight | 8.9% | 7.5–10.5% | |
| Severe underweight | 2.4% | 1.7–3.3% | |
CI = confidence interval; ID = iron deficiency; IDA = ID-anaemia; RBP = retinol-binding protein; VAD = vitamin A deficiency; OHD = hydroxycholecalciferol; VDD = vitamin D deficiency; VDI = vitamin D insufficiency; CRP = C-reactive protein; AGP = α1-acid glycoprotein; HA = height-for-age; WH = weight-for-height; WA = weight-for-age.
Means indicate unweighted counts while percentages were weighted for unequal probability of selection.
Considering the complex sampling design.
Defined as altitude-adjusted haemoglobin levels of <110 g/L.
Ferritin and RBP concentrations and associated deficiency prevalence rates were corrected for inflammation as per previously reported methods.18,19
ID was defined as serum ferritin levels of <12 μg/L and IDA as serum ferritin levels of <12 μg/L and haemoglobin levels of <110 g/L.
VAD was defined as RBP concentrations of <0.73 μmol/L.
VDD was defined as plasma 25-OHD levels of <30 nmol/L and VDI as plasma 25-OHD levels of 30–49.9 nmol/L.
Incubation was defined as CRP levels of >5 mg/L and AGP levels of <1 g/L, early convalescence as CRP levels of >5 mg/L and AGP levels of >1 g/L and late convalescence as CRP levels of ≤5 mg/L and AGP levels of >1 g/L.
Defined as <2,500 g.
Any stunting was defined as a HA z-score of less than −2 and severe stunting as a HA z-score of less than −3.
Any wasting was defined as a WH z-score of less than −2, severe wasting as a WH z-score of less than −3, normal as a WH z-score of −2 to 2, overweight as a WH z-score of 2–3 and obese as a WH z-score of >3.
Any underweight was defined as a WA z-score of <2 and severe underweight as a WA z-score of <3.
Prevalence of anaemia and micronutrient deficiencies by demographic characteristics among Omani children aged 6–59 months
| Characteristic | Anaemia | ID | IDA | VDD or VDI | VAD | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |
| 6–11 | 40.4 | 32.8–48.6 | 5.3 | 2.1–12.5 | 2.2 | 0.5–8.5 | 62.6 | 47.5–75.6 | 23.5 | 10.8–43.8 |
| 12–23 | 33.4 | 27.8–39.5 | 17.4 | 11.9–25.6 | 6.2 | 3.6–10.6 | 58.8 | 49.6–67.3 | 3.0 | 1.6–5.6 |
| 24–35 | 23.6 | 19.6–28.2 | 12.1 | 7.9–17.9 | 3.6 | 1.8–7.0 | 64.1 | 55.6–71.7 | 8.2 | 5.1–12.7 |
| 36–47 | 15.0 | 11.4–19.5 | 7.4 | 4.0–13.4 | 1.1 | 0.4–3.0 | 64.9 | 56.7–72.3 | 10.0 | 6.7–14.8 |
| 48–59 | 11.9 | 8.3–16.7 | 4.9 | 2.6–9.0 | 1.2 | 0.4–3.4 | 70.3 | 62.5–77.0 | 12.9 | 8.0–20.1 |
| Male | 23.8 | 20.6–27.1 | 11.7 | 8.6–15.7 | 3.7 | 2.3–6.0 | 60.1 | 54.7–65.2 | 9.9 | 6.8–14.1 |
| Female | 24.0 | 20.8–27.5 | 7.8 | 5.5–11.0 | 2.2 | 1.2–4.1 | 68.7 | 62.8–74.2 | 9.2 | 6.4–13.1 |
| Muscat | 18.1 | 9.9–30.7 | 7.3 | 2.4–20.5 | 0 | - | 65.9 | 53.1–76.7 | 9.5 | 4.1–20.6 |
| Dhofar | 15.4 | 11.6–20.1 | 41.8 | 29.8–54.8 | 8.9 | 4.6–16.5 | 78.8 | 68.1–86.6 | 8.6 | 5.5–13.2 |
| Ad Dhakhiliyah | 29.5 | 25.6–33.6 | 4.2 | 1.9–8.8 | 1.7 | 0.4–6.4 | 70.8 | 59.5–80.0 | 10.0 | 6.1–16.0 |
| Ash Sharqiyah North | 25.4 | 18.9–33.1 | 7.6 | 3.8–14.7 | 2.9 | 1.0–8.1 | 64.8 | 55.4–73.1 | 7.6 | 3.6–15.4 |
| Ash Sharqiyah South | 23.5 | 17.6–30.7 | 16.5 | 10.3–27.7 | 9.9 | 5.0–18.8 | 63.9 | 53.4–73.3 | 18.9 | 12.9–26.7 |
| Al-Batinah North | 23.0 | 17.0–30.2 | 6.1 | 2.6–13.4 | 2.0 | 0.6–7.1 | 66.7 | 56.4–75.5 | 8.1 | 4.3–14.8 |
| Al-Batinah South | 25.7 | 20.3–32.0 | 4.0 | 1.5–10.2 | 1.0 | 0.1–6.9 | 62.1 | 49.3–73.4 | 10.0 | 3.9–23.2 |
| Ad Dhahirah | 31.3 | 24.6–38.9 | 11.8 | 5.8–22.5 | 2.9 | 0.7–11.3 | 28.2 | 19.2–39.3 | 1.0 | 0.2–5.1 |
| Al-Buraimi | 21.5 | 16.4–27.7 | 3.4 | 1.5–7.4 | 0.9 | 0.1–5.7 | 63.8 | 53.1–73.3 | 5.0 | 2.3–10.3 |
| Musandam | 22.3 | 17.1–28.5 | 9.5 | 5.4–16.3 | 2.4 | 0.7–8.3 | 58.0 | 49.7–65.9 | 11.9 | 7.1–19.3 |
| Al-Wusta | 23.3 | 19.2–27.9 | 17.0 | 9.4–28.8 | 8.5 | 3.5–19.0 | 62.0 | 50.2–72.5 | 31.9 | 22.2–43.5 |
| Poorest | 27.5 | 21.1–34.8 | 4.9 | 2.2–10.8 | 3.3 | 1.1–9.3 | 66.8 | 55.6–76.3 | 11.6 | 6.0–21.2 |
| Poor | 25.6 | 21.1–30.6 | 7.9 | 4.5–13.3 | 2.3 | 1.2–4.7 | 56.0 | 45.5–65.9 | 16.1 | 11.0–22.9 |
| Middle | 24.0 | 19.6–28.9 | 7.7 | 4.7–12.4 | 3.8 | 1.7–8.4 | 69.5 | 61.3–76.6 | 8.3 | 4.4–15.1 |
| Wealthy | 26.6 | 21.0–33.1 | 10.3 | 5.7–17.7 | 3.3 | 1.6–6.7 | 66.0 | 57.5–73.5 | 7.6 | 4.3–13.3 |
| Wealthiest | 17.4 | 13.4–22.3 | 15.4 | 9.5–23.9 | 2.4 | 1.0–5.8 | 66.5 | 57.2–74.6 | 7.0 | 3.7–12.8 |
ID = iron deficiency; IDA = ID-anaemia; VDD = vitamin D deficiency; VDI = vitamin D insufficiency; VAD = vitamin A deficiency; CI = confidence interval.
Defined as altitude-adjusted haemoglobin levels of <110 g/L.
ID was defined as serum ferritin levels of <12 μg/L and IDA as serum ferritin levels of <12 μg/L and haemoglobin levels of <110 g/L. Serum ferritin levels were corrected for inflammation as per previously reported methods.18
VDD was defined as plasma 25-hydroxycholecalciferol levels of <30 nmol/L and VDI as plasma 25- hydroxycholecalciferol levels of 30–49.9 nmol/L.
Defined as retinol-binding protein concentrations of <0.73 μmol/L. Retinol-binding protein concentrations were corrected for inflammation as per previously reported methods.19
Weighted for unequal probability of selection.
Considering the complex sampling design.
P values of <0.050 indicate that at least one subgroup differs significantly from the others.
Overall P values for VDD and VDI by characteristic.
Figure 1Prevalence maps of (A) stunting (N = 2,920), (B) wasting (N = 2,869), (C) underweight (N = 2,945) and (D) overweight or obesity (N = 2,869) among Omani children aged 0–59 months
Stunting, wasting and underweight categories were based on World Health Organization classifications.
Micronutrient status indicators and prevalence of deficiencies among pregnant and non-pregnant Omani
| Parameter | Mean or prevalence | 95% CI | |
|---|---|---|---|
| (N = 4,122) | |||
| Haemoglobin in g/dL | 12.52 | 12.47–12.58 | |
| Anaemia | 27.8% | 25.9–29.8% | |
| Anaemia during pregnancy | 29.3% | 23.1–36.3% | |
| (N = 1,518) | |||
| Plasma ferritin in μg/L | 37.7 | 35.6–39.8 | |
| ID | 24.8% | 22.2–27.6% | |
| IDA | 13.3% | 11.2–15.8% | |
| (N = 1,520) | |||
| Plasma RBP in μmol/L | 1.47 | 1.44–1.50 | |
| VAD | 0.2% | 0.1–0.4% | |
| (N = 1,517) | |||
| Plasma 25-OHD in nmol/L | 18.4 | 17.9–19.0 | |
| VDD | 16.2% | 13.1–19.9% | |
| VDI | 41.5% | 37.7–45.4% | |
| (N = 1,495) | |||
| Serum folate in nmol/L | 7.51 | 7.23–7.79 | |
| Folate deficiency | 11.6% | 9.1–14.7% | |
| (N = 1,496) | |||
| Serum vitamin B12 in pmol/L | 389 | 375–404 | |
| Vitamin B12 deficiency | 8.9% | 6.9–11.4% | |
| (N = 1,499) | |||
| Sickle cell trait | 4.7% | 3.2–7.0% | |
| β-thalassaemia | 2.8% | 1.8–4.4% | |
| (N = 1,518) | |||
| CRP in mg/L | 4.4 | 4.0–4.9 | |
| AGP in g/L | 0.76 | 0.74–0.78 | |
| Incubation | 16.5% | 14.4–18.8% | |
| Early convalescence | 8.8% | 7.2–10.7% | |
| Late convalescence | 6.8% | 5.2–8.9% | |
| No inflammation | 67.9% | 64.7–71.0% | |
| (N = 4,159) | |||
| Any undernutrition | 9.1% | 7.9–10.5% | |
| Severe undernutrition | 1.6% | 1.1–2.2% | |
| Moderate undernutrition | 2.3% | 1.8–3.0% | |
| At risk | 5.2% | 4.3–6.2% | |
| Undernutrition during pregnancy | 5.0% | 2.8–9.0% | |
| (N = 4,159) | |||
| BMI in kg/m2 | 27.5 | 27.1–27.8 | |
| Normal | 31.7% | 29.9–33.5% | |
| Overweight or obese | 59.2% | 57.1–61.4% | |
| Overweight | 25.6% | 23.9–27.4% | |
| Obese | 33.6% | 31.7–35.6% | |
| High WHR | 47.5% | 45.1–49.8% | |
CI = confidence interval; ID = iron deficiency; IDA = ID-anaemia; RBP = retinol-binding protein; VAD = vitamin A deficiency; OHD = hydroxycholecalciferol; VDD = vitamin D deficiency; VDI = vitamin D insufficiency; CRP = C-reactive protein; AGP = α1-acid glycoprotein; BMI = body mass index; WHR = waist-to-hip ratio.
Means indicate unweighted counts while percentages were weighted for unequal probability of selection.
Considering the complex sampling design.
Defined as altitude-adjusted haemoglobin levels of <120 g/L for non-pregnant women and <110 g/L for pregnant women.
Ferritin and RBP concentrations and associated deficiency prevalence rates were corrected for inflammation as per previously reported methods.18,19
ID was defined as serum ferritin levels of <12 μg/L and IDA as serum ferritin levels of <12 μg/L and haemoglobin levels of <120 g/L.
Defined as RBP concentrations of <0.73 μmol/L.
VDD was defined as plasma 25-OHD levels of <30 nmol/L and VDI as plasma 25-OHD levels of 30–49.9 nmol/L.
Defined as serum folate levels of <10 nmol/L.
Defined as plasma B12 levels of <150 pmol/L.
Incubation was defined as CRP levels of >5 mg/L and AGP levels of <1 g/L, early convalescence as CRP levels of >5 mg/L and AGP levels of >1 g/L and late convalescence as CRP levels of ≤5 mg/L and AGP levels of >1 g/L.
Severe undernutrition was defined as a BMI of <16.0 kg/m2, moderate undernutrition as a BMI of 16.0–16.9 kg/m2, at risk of undernutrition as a BMI of 17.0–18.5 kg/m2, normal as a BMI of 18.5–24.9 kg/m2, overweight as a BMI of 25.0–29.9 kg/m2 and obese as a BMI of >30 kg/m2.
Defined as a mid-upper arm circumference of <23.0 cm.
Defined as a WHR of >0.85.
Prevalence of anaemia and micronutrient deficiencies by demographic characteristics among non-pregnant Omani women aged 15–49 years
| Characteristic | Anaemia | ID | IDA | VDD or VDI | Folate deficiency | VB12 deficiency | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |
| 15–19 | 28.8 | 24.1–34.0 | 32.1 | 25.3–39.8 | 14.3 | 9.7–20.7 | 73.9 | 65.3–81.0 | 13.7 | 9.0–20.3 | 9.5 | 5.9–14.9 |
| 20–24 | 20.5 | 16.8–24.8 | 24.3 | 18.2–31.7 | 12.8 | 8.1–19.6 | 68.8 | 58.9–77.1 | 18.8 | 12.5–27.3 | 12.4 | 8.0–18.7 |
| 25–29 | 23.0 | 19.1–27.4 | 13.7 | 9.5–19.4 | 6.6 | 3.8–11.4 | 54.1 | 45.2–62.7 | 11.1 | 7.1–17.0 | 10.5 | 6.4–17.0 |
| 30–34 | 28.9 | 24.6–33.6 | 22.9 | 16.8–30.4 | 9.1 | 5.0–16.1 | 54.1 | 44.3–63.6 | 9.6 | 5.8–15.5 | 11.1 | 7.5–16.1 |
| 35–39 | 27.2 | 23.1–32.0 | 25.4 | 19.2–32.8 | 14.3 | 9.4–21.2 | 52.1 | 41.9–62.1 | 9.3 | 5.3–15.6 | 8.1 | 4.3–14.7 |
| 40–44 | 33.5 | 28.0–39.5 | 32.1 | 23.8–41.8 | 21.1 | 14.4–29.9 | 46.7 | 38.0–55.6 | 10.0 | 6.1–15.8 | 5.7 | 3.0–10.6 |
| 45–49 | 38.6 | 31.7–46.0 | 25.0 | 16.9–35.4 | 18.6 | 11.4–28.9 | 51.2 | 40.0–62.2 | 6.1 | 3.1–11.7 | 1.3 | 0.4–4.9 |
| Muscat | 28.0 | 23.1–33.5 | 27.2 | 21.1–34.2 | 16.6 | 11.4–23.4 | 44.1 | 35.4–53.1 | 11.8 | 6.8–19.9 | 2.0 | 0.7–5.5 |
| Dhofar | 28.0 | 23.1–33.5 | 28.2 | 22.5–34.7 | 9.0 | 6.2–12.9 | 84.6 | 75.0–91.0 | 47.7 | 36.4–59.3 | 20.0 | 10.2–35.5 |
| Ad Dhakhiliyah | 27.5 | 23.2–32.3 | 16.1 | 9.4–26.3 | 8.6 | 4.3–16.5 | 49.5 | 38.6–60.3 | 6.5 | 3.0–13.3 | 3.2 | 0.8–12.8 |
| Ash Sharqiyah North | 24.6 | 9.5–30.5 | 18.5 | 12.7–26.2 | 9.6 | 5.8–15.5 | 89.6 | 35.4–53.1 | 2.9 | 0.9–9.2 | 16.9 | 10.5–26.1 |
| Ash Sharqiyah South | 23.0 | 7.5–29.6 | 25.5 | 19.6–32.5 | 11.0 | 7.3–16.4 | 84.8 | 75.0–91.0 | 21.9 | 15.0–30.8 | 22.6 | 15.5–31.7 |
| Al-Batinah North | 32.6 | 27.6–38.1 | 22.5 | 16.1–30.5 | 14.7 | 9.1–23.0 | 19.4 | 38.6–60.3 | 7.3 | 3.7–14.1 | 7.3 | 3.0–16.4 |
| Al-Batinah South | 29.5 | 24.5–35.0 | 30.7 | 24.7–37.4 | 15.7 | 10.3–23.2 | 88.6 | 82.3–94.1 | 1.6 | 0.4–6.3 | 9.5 | 5.8–15.3 |
| Ad Dhahirah | 31.1 | 26.9–35.8 | 33.1 | 24.2–43.4 | 18.0 | 11.7–26.7 | 81.2 | 75.5–91.0 | 4.4 | 1.8–10.1 | 4.4 | 1.1–15.7 |
| Al-Buraimi | 38.8 | 32.5–45.6 | 28.3 | 19.0–40.0 | 13.2 | 9.2–18.6 | 70.7 | 13.7–26.6 | 11.4 | 6.0–20.6 | 21.5 | 14.6–30.6 |
| Musandam | 30.4 | 25.0–36.3 | 31.5 | 20.9–44.4 | 17.3 | 10.9–26.4 | 80.9 | 81.3–93.3 | 3.7 | 1.6–8.5 | 10.6 | 7.9–13.9 |
| Al-Wusta | 15.1 | 10.5–21.3 | 27.8 | 20.2–36.9 | 5.6 | 3.2–9.5 | 37.0 | 72.7–87.5 | 2.8 | 0.9–8.7 | 13.0 | 6.1–25.3 |
| Poorest | 29.1 | 23.7–35.1 | 28.8 | 19.5–40.3 | 19.2 | 10.9–31.6 | 52.9 | 39.3–66.1 | 10.8 | 6.0–18.7 | 9.3 | 5.2–16.1 |
| Poor | 27.3 | 23.0–32.1 | 24.0 | 18.4–30.7 | 14.6 | 10.2–20.5 | 59.8 | 48.2–70.4 | 9.0 | 5.0–15.6 | 11.1 | 6.7–17.9 |
| Middle | 26.6 | 22.0–31.8 | 15.3 | 10.0–22.7 | 6.5 | 3.3–12.4 | 57.0 | 46.6–66.9 | 11.3 | 7.2–17.3 | 12.8 | 8.2–19.4 |
| Wealthy | 27.5 | 23.8–31.6 | 23.4 | 18.2–29.5 | 13.2 | 9.1–19.0 | 59.0 | 48.3–68.9 | 11.5 | 7.5–17.2 | 8.6 | 5.4–13.4 |
| Wealthiest | 28.9 | 25.6–32.5 | 29.7 | 24.4–35.7 | 15.1 | 11.1–20.3 | 56.7 | 49.2–63.9 | 13.0 | 8.8–18.8 | 6.3 | 3.9–9.8 |
ID = iron deficiency; IDA = ID-anaemia; VDD = vitamin D deficiency; VDI = vitamin D insufficiency; VB12 = vitamin B12; CI = confidence interval.
Defined as altitude-adjusted haemoglobin levels of <120 g/L.
ID was defined as serum ferritin levels of <12 μg/L and IDA as serum ferritin levels of <12 μg/L and haemoglobin levels of <110 g/L. Serum ferritin levels were corrected for inflammation as per previously reported methods.18
VDD was defined as plasma 25-hydroxycholecalciferol levels of <30 nmol/L and VDI as plasma 25-hydroxycholecalciferol levels of 30–49.9 nmol/L.
Defined as plasma folate concentrations of <10 nmol/L.
Defined as serum vitamin B12 levels of <150 pmol/L.
Weighted for unequal probability of selection.
Considering the complex sampling design.
P values of <0.050 indicate that at least one subgroup differs significantly from the others.
Overall P values for VDD and VDI by characteristic.
Figure 2Prevalence maps of (A) underweight, (B) overweight and (C) obesity among non-pregnant Omani women aged 15–49 years (N = 4,159).
Underweight, overweight, and obesity categories were based on World Health Organization classifications.